Faisal Kerjit
Analyst
Jefferies
Equibles does not estimate personal net worth.
About Faisal Kerjit
Faisal Kerjit is recorded as Analyst at Jefferies. Faisal Kerjit has spoken on 1 earnings call across 1 company, most recently for Kymera Therapeutics, Inc. on August 5, 2026. The companies whose calls Faisal Kerjit spoke on are classified in the Healthcare sector.
Faisal Kerjit on recent calls
“I just wanted to ask your kind of latest and greatest thoughts on the competitive landscape. And I'm wondering both within the stat six class, like yesterday we had Pfizer confirming that their stat six is active in phase two and Nurex and Sanofi dosing their program.”
Affiliation history
-
Jefferies
Analyst
Transcript header (unverified)
Current